Navigation Links
EuroPCR 2014 examines whether science translates into practice with new session format
Date:5/22/2014

22 May 2014, Paris, France: The value of analysing published clinical trials and the benefit of informed discussion were highlighted yesterday when the ACCOAST trial data were discussed in a new session formatWill this trial change my practice? at EuroPCR 2014. ACCOAST trial results demonstrate that pre-treatment with prasugrel in NSTEMI patients undergoing percutaneous coronary intervention (PCI) is inferior to treatment with the drug after angiography. Several other trials are also being scrutinised in the same format, which ends with a discussion with the audience members on whether the trial results would change their practice or not.

Speaking on the value of the session format, panellist Andreas Baumbach, University of Bristol, UK, said: "There is a need to translate what we read in published journals as trials, ie. the science, to what it means for the practitioner on a daily basis. What does it actually mean when a trial says that this treatment is better, or not, than another one. What does this information finally mean for the patient I am treating? This format is trying to get knowledgeable people, including a trialist, to talk about the specifics of the trial as it is published in order to tease out the data from it that are most relevant for our practice."

The session encourages practitioners to compare the population treated in the trial to the population they treat in daily practice. It also encourages practitioners to question whether the technique used is comparable to the one they employ, and to analyse the endpoints that have been chosen in the trial in order to see if they are relevant for patients.

The ACCOAST trial evaluated the effect of administering the P2Y12 antagonist prasugrel at the time of diagnosis versus administering it after the coronary angiography, if percutaneous coronary intervention (PCI) was indicated. Investigators studied 4,033 patients with NSTE acute coronary syndromes and a positive troponin level who were
'/>"/>

Contact: Isabelle Uzielli
iuzielli@europcr.com
EuroPCR
Source:Eurekalert

Page: 1 2

Related medicine news :

1. CRF will Provide updates on several key cardiovascular trials at EuroPCR
2. New ESC-EACTS guidelines on myocardial revascularization to be released at EuroPCR 2014
3. EuroPCR 2014 showcases technological advances in complex cardiovascular interventions
4. Personalizing revascularization strategy for STEMI patients is vital, EuroPCR panel finds
5. Study examines medicare use for Mohs micrographic surgery and surgical excision for skin cancer
6. Study examines drug regimen for the treatment of non-small cell lung cancer among older patients
7. Study examines adverse effects among different radiation therapies for prostate cancer
8. LA BioMeds Dr. John Tsuang examines effects of Ibudilast and metamphetamines
9. Study examines benefit of follow-up CT when abdominal ultrasound inconclusive
10. Research examines when benefits of screening mammography outweigh the harms for women in their 40s
11. Study examines necessity of additional imaging in PET/CT oncologic reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... August 21, 2014 AttorneyOne.com, a recognized ... the latest information from the FDA on Dianeal ... US FDA announced on August 15, that two lots ... 2.5% Dextrose 5000mL (Ambu-Flex II), by Baxter International Inc., ... particulate matter. , The reason for the recall ...
(Date:8/21/2014)... TX (PRWEB) August 21, 2014 Sometimes you have ... , In his new book “From Zero to a Hundred: Finding ... officer, shares his story of surviving a broken family, a childhood ... brings affirmation of who you were created to be,” Roy said. ... which is why I know my purpose today of helping others ...
(Date:8/21/2014)... 2014 OpsAssure, the local start-up ... to participate in the Harbor Accelerator's 14 week ... sessions and valuable resources.he Harbor’s goal is to ... Each start-up selected for the program receives a ... help businesses grow quickly, test markets and become ...
(Date:8/21/2014)... Today, Fecbek.com, a leading wedding dresses ... of wedding dresses. And all these elegant, gorgeous and ... excellent designers. , A wedding dress or wedding gown ... wedding ceremony. Color, style and ceremonial importance of the ... the wedding participants. In order to satisfy every customer, ...
(Date:8/20/2014)... Fancyflyingfox.com, the popular online supplier of wedding ... a new collection of 2014 military ball gowns ... promotion for these trendy and elegant products. , ... special offer to show its appreciation to the global ... ball outfits are provided with deeply discounted prices, up ...
Breaking Medicine News(10 mins):Health News:Dianeal Low Calcium (2.5mEq/L) Peritoneal Dialysis Solution with 2.5% Dextrose 5000mL (Ambu-Flex II) Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Zero to a Hundred: True Story of Escaping Death to Meet Life 2Health News:Elegant Wedding Dresses Are for Sale at Fecbek.com 2Health News:2014 Military Ball Gowns Offered At Popular Online Store Fancyflyingfox.com 2
... VIRGINIA BEACH, Va., June 10 AMERIGROUP,Corporation (NYSE: ... full-year,2008 guidance of $2.35 to $2.45 per diluted share ... of Tennessee. As previously,announced, the Company will present at ... In the first quarter of 2008, AMERIGROUP disclosed higher ...
... of Christopher,Grell have filed a lawsuit against Herbalife Ltd. ... State of California (case BC392373, dept. 48) today,on behalf ... after,taking Herbalife products., The lawsuit, which also names ... Phillis Chen, a resident,of the State of California, suffered ...
... June 10 Mylan Inc. (NYSE: MYL ),announced ... Federal Circuit has,affirmed a May 2007 District Court ruling ... capsules do not infringe patents asserted,against Mylan by AstraZeneca. ... Mylan launched its Omeprazole products on August 4, 2003, ...
... June 10 More and more people today ... difficult to get and,stay healthy. This National Men,s ... that are helping people who are uninsured but,need ... this report from Pfizer (NYSE: PFE ) ...
... items keep addiction affordable, study says , , ... the United States have declined in recent years, but ... the decline in cigarette sales by 30 percent, a ... analyzed federal government data and found that between 2000 ...
... helped with depression, agitation in elderly , , TUESDAY, June ... may ease some of the behavioral problems associated with ... a hormone which seems to play a role in ... night. , Both strategies could greatly improve quality of ...
Cached Medicine News:Health News:AMERIGROUP Provides Status on Tennessee Rate Increase and Effect on 2008 Guidance 2Health News:AMERIGROUP Provides Status on Tennessee Rate Increase and Effect on 2008 Guidance 3Health News:AMERIGROUP Provides Status on Tennessee Rate Increase and Effect on 2008 Guidance 4Health News:AMERIGROUP Provides Status on Tennessee Rate Increase and Effect on 2008 Guidance 5Health News:Herbalife Sued for Negligence and Fraud by Victim 2Health News:Decline in Cigarette Sales Offset by Use of Alternative Products 2Health News:Adding Light Eases Behavioral Problems of Dementia 2Health News:Adding Light Eases Behavioral Problems of Dementia 3
(Date:8/20/2014)... , Aug. 20, 2014  Decision ... (EP) mapping and ablation device market will ... ablation to treat atrial fibrillation (AF). The ... treatment option for AF will spur adoption ... application, such as advanced loop diagnostic catheters, ...
(Date:8/20/2014)...  Amerigen Pharmaceuticals Ltd. announces that its Chinese ... Chinese FDA (CFDA) approval and has subsequently launched ... China domestic market.  Under ... with Sinochem Jiangsu Pharmaceutical Co., Ltd., Amerigen is ... and China CFDA certified oral solid dose facility ...
(Date:8/20/2014)... NEW YORK , Aug. 20, 2014 ... available in its catalogue: Global Feminine Hygiene ... This report analyzes the worldwide markets for Feminine ... Segments: Sanitary Pads/Towels, Tampons, Panty liners, and Others. The ... Canada , Japan , ...
Breaking Medicine Technology:Electrophysiology Mapping and Ablation Device Market in Japan to Reach $1.1 Billion by 2023 2Electrophysiology Mapping and Ablation Device Market in Japan to Reach $1.1 Billion by 2023 3Amerigen Pharmaceuticals Ltd. announces that its Chinese subsidiary, Suzhou Amerigen Pharmaceuticals Co. Ltd., has received Chinese FDA (CFDA) approval and has subsequently launched its generic Mecobalamin 0.5 mg Tablets into the China domestic mark 2Global Feminine Hygiene Products Industry 2Global Feminine Hygiene Products Industry 3Global Feminine Hygiene Products Industry 4Global Feminine Hygiene Products Industry 5Global Feminine Hygiene Products Industry 6Global Feminine Hygiene Products Industry 7Global Feminine Hygiene Products Industry 8Global Feminine Hygiene Products Industry 9Global Feminine Hygiene Products Industry 10Global Feminine Hygiene Products Industry 11Global Feminine Hygiene Products Industry 12Global Feminine Hygiene Products Industry 13Global Feminine Hygiene Products Industry 14Global Feminine Hygiene Products Industry 15Global Feminine Hygiene Products Industry 16Global Feminine Hygiene Products Industry 17Global Feminine Hygiene Products Industry 18Global Feminine Hygiene Products Industry 19Global Feminine Hygiene Products Industry 20Global Feminine Hygiene Products Industry 21Global Feminine Hygiene Products Industry 22Global Feminine Hygiene Products Industry 23Global Feminine Hygiene Products Industry 24Global Feminine Hygiene Products Industry 25Global Feminine Hygiene Products Industry 26
... Drug Screen Tests are available in 14 ... (Ecstasy). Designed using Microgenics Antibody Technology, the ... point of care immunoassay targeted to detect ... MDA and MDEA but no cross-reactivity to ...
... drugs of abuse tests are highly accurate in ... recommended cut-off as confirmed by GC/MS testing. The ... specific alternative method (such as GC/MS) must be ... Professional judgment should be applied to any drug ...
... InstaCheck® multi-drug test device provides ... easily. Negative results can be ... 3 minutes; positive results require ... one-time urine sample application will ...
... Drug Screen Tests are available in 14 ... (Ecstasy). Designed using Microgenics Antibody Technology, the ... point of care immunoassay targeted to detect ... MDA and MDEA but no cross-reactivity to ...
Medicine Products: